With Enhanced Expression News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Capricor Therapeutics Announces New Advances in Exosome-Mediated mRNA Delivery Platform
-New Data Demonstrates Exosome-Mediated Delivery of mRNAs With Enhanced Expression and Lower Toxicity Compared to Lipid Nanoparticles-
-Functional Enzyme Expression and Real-Time Imaging of mRNA Expression in Live Animals-
-Platform for Advancing Clinical Development of Exosome-RNA Based Vaccine Candidate-
-Data to be Discussed on Earnings Call this Thursday, March 11 at 4:30 p.m. ET-
LOS ANGELES, March 09, 2021 (GLOBE NEWSWIRE) Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company focused on the development of transformative cell- and exosome-based therapeutics for the treatment and prevention of a broad spectrum of diseases, in collaboration with researchers, announced today that new advances from its positive preclinical study for a multivalent exosome-based mRNA vaccine for COVID-19 have been posted on the bioRxiv preprint server and has been submitted fo ....

Caitlin Kasunich Raquel Cona , Linda Marb , Stephen Gould , Joyce Allaire , Lifesci Advisors , Exchange Commission On , Company Contact , Drug Administration , Strategic Communications , Capricor Therapeutics Inc , New Data Demonstrates Exosome Mediated Delivery , With Enhanced Expression , Lower Toxicity Compared , Functional Enzyme Expression , Real Time Imaging , Advancing Clinical Development , Earnings Call , Capricor Therapeutics , Lipid Nanoparticle , Executive Consultant , Private Securities Litigation Reform Act , Annual Report , Exchange Commission , Quarterly Report , Investigational New Drug , Sci Advisors ,